Clinical Trials

Pancreatic Neoplasms

NCT03443492 2025-12-30

Pancreas

130 enrolled

Pancreatic Neoplasms

NCT06584227 2025-12-08

ACPC

Phase 2 Recruiting

45 enrolled

Phase 4 Not yet recruiting

Pancreatic cancer, adult, Pancreatic Neoplasms

NCT06779318 2025-04-03

Maintenance Chemotherapy With S-1 vs. Observation After Adjuvant Therapy for Resected Pancreatic Cancer With High Risk of Recurrence/Metastasis

464 enrolled

Pancreatic Neoplasms

NCT05218889 2024-12-31

Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer

Phase 1/2 Recruiting

90 enrolled

Pancreatic Neoplasms

NCT00651742 2024-09-19

Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic Cancer

28 enrolled 16 charts

Pancreatic Neoplasms

NCT00652054 2024-09-03

Phase 2 Study of S-1 as 2nd Line Therapy in Metastatic Pancreatic Cancer

39 enrolled

Pancreatic Neoplasms

NCT05048524 2024-03-27

Peri-operative SLOG for Localized Pancreatic Cancer

Phase 2 Recruiting

64 enrolled

Phase 2 Not yet recruiting

Pancreatic Neoplasms

NCT06166589 2023-12-12

Second-line Zimberelimab and SIRIOX Chemotherapy for Patient With Previously AG Chemotherapy Treated Pancreatic Cancer

19 enrolled

Pancreatic Neoplasms

NCT03162510 2022-04-07

SOLAR

Phase 1 Completed

18 enrolled

Biliary Tract Neoplasms, Pancreatic Neoplasms

NCT05138159 2021-11-30

A Study of Donafenib Plus S-1 in Treating Patients With Metastatic Pancreatic Cancer After Chemotherapy With Nab-paclitaxel Plus Gemcitabine Regimen

10 enrolled

Pancreatic Neoplasms

NCT04808687 2021-03-22

Neoadjuvant Nab-Paclitaxel and S-1 in Resectable Pancreatic Cancer

72 enrolled

Pancreatic Neoplasms

NCT03986294 2021-01-15

NAPAN

122 enrolled

Pancreatic Neoplasms

NCT03585062 2021-01-08

Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin on Pancreatic Cancer

Phase 2 Terminated

40 enrolled

Pancreatic Neoplasms

NCT02459652 2020-10-27

Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer

57 enrolled

Pancreatic Neoplasms

NCT02704143 2020-10-19

Combination of SBRT With Sequential S-1 for Treating Locally Advanced Pancreatic Cancer

Phase NA Completed

63 enrolled 13 charts

Pancreatic Neoplasms

NCT00429858 2020-09-18

Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Phase 2 Terminated

21 enrolled 8 charts

Pancreatic Neoplasms

NCT04377048 2020-05-06

Nivolumab Adding on Gemcitabine/S-1 in Metastatic Pancreatic Cancer

38 enrolled

Pancreatic Neoplasms

NCT03825328 2019-01-31

A Trial of NS/GEMOX Chemotherapy in Patients With Untreated Pancreatic Cancer ( HZ-NS/GEMOX-PC )

30 enrolled

Pancreatic Neoplasms

NCT03636308 2018-08-17

ASAGPAC

40 enrolled

Pancreatic Neoplasms

NCT01781520 2018-01-18

Study of S-1 Plus DC-CIK for Patients With Unresectable Locally Advanced Pancreatic Cancer

Phase 1/2 Completed

47 enrolled

Pancreatic Neoplasms

NCT01430052 2017-11-21

Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic Cancer

110 enrolled

Pancreatic Neoplasms

NCT01693419 2017-08-23

S-1, Gemcitabine and Erlotinib for Advanced Pancreatic Cancer

37 enrolled

Pancreatic Neoplasms

NCT02734680 2017-04-11

IFCSLAPC

Phase NA Unknown

70 enrolled

Pancreatic Neoplasms

NCT02945267 2016-10-26

Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer

Phase 4 Unknown

60 enrolled

Pancreatic Neoplasms

NCT00602745 2016-05-26

S-1 Pancreas

Phase 3 Terminated

61 enrolled

Neoplasm Metastasis, Pancreatic Neoplasms

NCT02634502 2015-12-18

Radiofrequency Ablation Combined With S-1 for Pancreatic Cancer With Liver Metastasis

30 enrolled

Pancreatic Neoplasms

NCT01074996 2014-01-16

APC-S1

92 enrolled

Pancreatic Neoplasms

NCT00514163 2011-06-28

GEM vs GEM+TS-1 for Advanced Pancreatic Cancer

110 enrolled

Pancreatic Neoplasms

NCT00209677 2007-11-01

Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

Phase 1/2 Suspended

40 enrolled

Pancreatic Neoplasms

NCT00197431 2006-03-22

Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer